Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$519M |
| 2 |
Netflix
NFLX
|
+$448M |
| 3 |
Qualcomm
QCOM
|
+$280M |
| 4 |
Microsoft
MSFT
|
+$252M |
| 5 |
Broadcom
AVGO
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$453M |
| 2 |
ExxonMobil
XOM
|
+$234M |
| 3 |
GMS
GMS Inc
GMS
|
+$217M |
| 4 |
SKX
Skechers
SKX
|
+$201M |
| 5 |
Capital One
COF
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 17.99% |
| 3 | Industrials | 12.15% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Healthcare | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Pulmonx
LUNG
$49.4M
| $558K | ﹤0.01% |
344,467
-110,877
| -24% | -$232K |
|
2977
Tyra Biosciences
TYRA
$1.82B
| $555K | ﹤0.01% |
39,679
-2,002
| -5% | -$22.8K |
|
2978
Townsquare Media
TSQ
$113M
| $555K | ﹤0.01% |
82,599
+8,691
| +12% | +$62.9K |
|
|
KALV
2979
DELISTED
KalVista Pharmaceuticals
KALV
| $554K | ﹤0.01% |
45,444
-127,765
| -74% | -$1.77M |
|
2980
Expensify
EXFY
$166M
| $552K | ﹤0.01% |
297,856
-83,090
| -22% | -$168K |
|
|
SLNO
2981
DELISTED
Soleno Therapeutics
SLNO
| $548K | ﹤0.01% |
+8,102
| New | +$601K |
|
2982
Brookfield Asset Management
BAM
$74B
| $547K | ﹤0.01% |
9,606
-264
| -3% | -$15.7K |
|
2983
Comstock Holding Companies
CHCI
$152M
| $543K | ﹤0.01% |
38,775
+2,704
| +7% | +$38.8K |
|
|
PCH
2984
DELISTED
PotlatchDeltic
PCH
| $540K | ﹤0.01% |
+13,259
| New | +$549K |
|
2985
NetSol Technologies
NTWK
$51.7M
| $532K | ﹤0.01% |
111,976
+2,729
| +2% | +$11.4K |
|
|
JFIN
2986
Jiayin Group
JFIN
$113M
| $520K | ﹤0.01% |
+50,413
| New | +$687K |
|
2987
Mirum Pharmaceuticals
MIRM
$6.89B
| $514K | ﹤0.01% |
+7,018
| New | +$446K |
|
2988
AC Immune
ACIU
$227M
| $513K | ﹤0.01% |
177,111
-21,575
| -11% | -$48.7K |
|
2989
MIND Technology
MIND
$50.4M
| $513K | ﹤0.01% |
63,423
-106
| -0.2% | -$953 |
|
2990
Barnes & Noble Education
BNED
$412M
| $511K | ﹤0.01% |
51,365
+4,770
| +10% | +$44.5K |
|
2991
Bank Of The James
BOTJ
$122M
| $510K | ﹤0.01% |
32,665
| – | – |
|
2992
Bluerock Homes Trust
BHM
$34.4M
| $508K | ﹤0.01% |
42,425
-375
| -0.9% | -$4.87K |
|
2993
Cardlytics
CDLX
$21M
| $507K | ﹤0.01% |
20,843
-10,082
| -33% | -$168K |
|
|
THRD
2994
DELISTED
Third Harmonic Bio
THRD
| $505K | ﹤0.01% |
93,939
| – | – |
|
2995
Hennessy Advisors
HNNA
$77.6M
| $504K | ﹤0.01% |
47,828
-14,900
| -24% | -$176K |
|
2996
4D Molecular Therapeutics
FDMT
$526M
| $504K | ﹤0.01% |
58,006
+2,069
| +4% | +$12.4K |
|
2997
Seer Inc
SEER
$108M
| $498K | ﹤0.01% |
229,181
-2,271
| -1% | -$4.83K |
|
2998
Live Ventures
LIVE
$29.8M
| $494K | ﹤0.01% |
26,910
-5,126
| -16% | -$86.8K |
|
2999
Coda Octopus Group
CODA
$113M
| $494K | ﹤0.01% |
61,561
+1,562
| +3% | +$12.3K |
|
3000
Skillsoft
SKIL
$56.9M
| $494K | ﹤0.01% |
37,938
-628
| -2% | -$9.22K |
|
Similar funds
Dimensional Fund Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Dimensional Fund Advisors held 3,356 positions worth $466B, up 7.9% from $432B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q3 2025 filing shows 84 new, 1,582 increased, 1,511 reduced and 85 closed positions. Its largest new stake was Qiagen: 1,300,037 shares worth $58.1M. The largest sale was Hess, an estimated $453M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q3 2025 buy was Qiagen: 1,300,037 shares worth $58.1M.
- Dimensional Fund Advisors added most to Chevron in Q3 2025, an estimated $519M increase.
- Dimensional Fund Advisors's biggest Q3 2025 reduction was ExxonMobil, cutting an estimated $234M.
- Dimensional Fund Advisors fully exited Hess in Q3 2025, selling an estimated $453M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $466B portfolio in Q3 2025.
- Dimensional Fund Advisors opened 84 new positions and closed 85 in Q3 2025.
- Dimensional Fund Advisors's portfolio value rose 7.9% quarter-over-quarter to $466B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.